Komori
Bando Chemical Industries (5195) · InitiativeEstablishment of a new treasury share acquisition limitLatest Results briefing materials (2026-08-07): "Advanced"

Flexible capital policy through share repurchases

First written in FY2017. 17 of 23 entries say "Advanced", first in FY2018. Latest entry: 2026-08-07.

23entries
10years
6from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2018 – 2026-05-142017: 120172018: 120182019: 020192020: 120202021: 320212022: 420222023: 120232024: 320242025: 220252026: 72026
Same theme, other companies
Flexible Shareholder Returns and Capital Policy Through Board AuthorityA theme 410 companies write about · 0 as a headwind · 411 as a tailwind

95 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 199 companies compared. The sentences above are computed from all 199.Comparing 200 of the theme's 411 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026Establishment of a new treasury share acquisition limitAnnual report

    「Status of resolution by the Board of Directors (14 May 2026) (acquisition period: 15 May 2026–30 April 2027) 1,300,000 2,000,000,000」

    On 14 May 2026, the company resolved to establish a new treasury share acquisition limit of 1.3 million shares and ¥2 billion in total, with an acquisition period from 15 May 2026 through 30 April 2027. Under the previous fiscal year's acquisition limit, the company acquired 1,065,500 shares for approximately ¥2 billion.
  2. FY2026-H1AdvancedAnnual report

    「Expenditures for the acquisition of treasury shares △ 1,181」

    During the current interim consolidated accounting period, the company recorded ¥1,181 million in expenditures for the acquisition of treasury shares and continued its flexible capital policy through treasury share acquisitions.
  3. FY2025RaisedAnnual report

    「Status of resolution by the Board of Directors (15 May 2025) (acquisition period: 16 May 2025–30 April 2026) 1,800,000 2,000,000,000」

    Regarding the new treasury share acquisition limit, the company increased the maximum number of shares from 1.5 million shares in the previous fiscal year to 1.8 million shares, while maintaining the total amount at ¥2 billion.
  4. FY2025-H1AdvancedAnnual report

    「Expenditures for the acquisition of treasury shares △982」

    During the current interim consolidated accounting period, the company recorded ¥982 million in expenditures for the acquisition of treasury shares and continued its flexible capital policy.
  5. FY2024RaisedAnnual report

    「Status of resolution by the Board of Directors (15 May 2024) (acquisition period: 16 May 2024–30 April 2025) 1,500,000 2,000,000,000」

    Regarding the acquisition of treasury shares, the company resolved on 15 May 2024 to establish a new acquisition limit of 1.5 million shares and ¥2 billion in total, expanding the previous acquisition limit.
  6. FY2024-Q3AdvancedAnnual report

    「Expenditures for the acquisition of treasury shares △438」

    During the third quarter of the current consolidated cumulative period, the company recorded ¥438 million in expenditures for the acquisition of treasury shares and continued its flexible capital policy.
  7. FY2023-Q3AdvancedAnnual report

    「Expenditures for the acquisition of treasury shares △769」

    During the third quarter of the current consolidated cumulative period, the company recorded ¥769 million in expenditures for the acquisition of treasury shares and continued acquiring treasury shares.
  8. FY2023-Q2AdvancedAnnual report

    「Expenditures for the acquisition of treasury shares △448」

    During the second quarter of the current consolidated cumulative period, the company recorded ¥448 million in expenditures for the acquisition of treasury shares and continued acquiring treasury shares.
  9. FY2023-Q1AdvancedAnnual report

    「Expenditures for the acquisition of treasury shares △159」

    During the first quarter of the current consolidated cumulative period, the company recorded ¥159 million in expenditures for the acquisition of treasury shares and continued acquiring treasury shares.
  10. FY2022AdvancedAnnual report

    「Treasury shares acquired during the fiscal year 1,119,700 shares, ¥999,926,839」

    Under the treasury share acquisition limit resolved on 13 May 2021, the company acquired 1,119,700 shares for approximately ¥1 billion during the fiscal year.
  11. FY2022-Q3AdvancedAnnual report

    「Expenditures for the acquisition of treasury shares △990」

    During the third quarter of the current consolidated cumulative period, the company recorded ¥990 million in expenditures for the acquisition of treasury shares and continued acquiring treasury shares.
  12. FY2022-Q2AdvancedAnnual report

    「Expenditures for the acquisition of treasury shares △463」

    During the second quarter of the current consolidated cumulative period, the company recorded ¥463 million in expenditures for the acquisition of treasury shares and continued acquisitions based on the resolution of the Board of Directors in May 2021.
  13. FY2022-Q1AdvancedAnnual report

    「Expenditures for the acquisition of treasury shares △153」

    During the first quarter of the current consolidated cumulative period, the company recorded ¥153 million in expenditures for the acquisition of treasury shares and continued acquisitions based on the resolution of the Board of Directors in May 2021.
  14. FY2021AdvancedAnnual report

    「Status of resolution by the Board of Directors (13 May 2021) (acquisition period: 14 May 2021–31 March 2022) 1,600,000 1,000,000,000」

    At a meeting of the Board of Directors held on 13 May 2021, the company resolved to establish an acquisition limit of 1.6 million treasury shares for a total of ¥1 billion, with an acquisition period from 14 May 2021 through 31 March 2022.
  15. FY2020-Q3AdvancedAnnual report

    「At a meeting of the Board of Directors held on 11 November 2019, the company resolved to acquire treasury shares and determined the specific acquisition method pursuant to Article 156 of the Companies Act as applied mutatis mutandis under Article 165, paragraph 3 of the Act, and carried out the acquisition as follows: ① Class of shares acquired: the company's common shares ② Total number of shares acquired: 478,500 shares ③ Acquisition cost: ¥472 million ④ Acquisition date: 12 November 2019」

    For the purpose of flexible capital policy, the company acquired 478,500 treasury shares for ¥472 million on 12 November 2019.
  16. FY2018AdvancedAnnual report

    「Treasury shares acquired during the fiscal year 133,500 152,457,000」

    Based on a resolution of the Board of Directors dated 9 August 2017, the company acquired 133,500 treasury shares during the fiscal year, worth ¥152 million.
  17. FY2017First statedAnnual report

    「Status of resolution by the Board of Directors (14 March 2016) (acquisition period: 15 March 2016–30 September 2016) 2,000,000 1,000,000,000」

    Regarding the acquisition of treasury shares based on a resolution of the Board of Directors, the company disclosed an acquisition limit of ¥2 billion and 2 million shares, and the acquisition of 1.639 million shares during the fiscal year. The Articles of Incorporation also permit the Board of Directors to acquire treasury shares to enable flexible capital policy.
Moved together

"Evolution of the Global Market Strategy" moved the same way as this thread, in the same document, in 18 of its 23 moves.

181312121110★123456
  1. ★This thread
  2. 1Evolution of the Global Market Strategy18×
  3. 2Creating New Businesses and Developing New Markets13×
  4. 3Zero Net Interest-Bearing Debt12×
  5. 4Development of Market-Optimized Specifications and High-Value-Added Products12×
  6. 5Borrowing and Securing On-Hand Liquidity in Preparation for a Prolonged COVID-19 Pandemic11×
  7. 6Expansion of the Medical Devices Business through the Acquisition of Aimedic MMT10×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Bando Chemical Industries yet. It last moved in the Results briefing materials of 2026-08-07: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Flexible capital policy through share repurchases | Bando Chemical Industries,Ltd. (5195) | Komori